BRS-X(Hormones-FM1) - Reproductive Hormone Balance & Neurocognitive Regulation
(Sex Hormones, Metabolism & Brain Function)
1. Definition
Supports integrated regulation of oestrogen, progesterone, gut-mediated sex-hormone metabolism, and metabolic–reproductive hormone signalling, influencing neurocognitive stability through coordinated hormone signalling, enterohepatic recycling, microbial metabolism, and insulin-linked endocrine regulation. Circulating sex hormones are bidirectionally coupled to gut microbial ecology via the estrobolome (microbiome-mediated oestrogen metabolism and recycling).
- Coordinates oestrogen, progesterone, and androgen signalling with neurocognitive context.
- Links gut estrobolome and microbial metabolism to sex-hormone exposure — Supporting BRS5.
- Integrates insulin and metabolic signals with reproductive hormone balance — Supporting BRS6.
2. Primary Biological Effects
↑ coordinated reproductive hormone signalling; ↑ gut-mediated sex-hormone metabolism context; ↑ metabolic-reproductive integration; ↓ uncoupled hormonal volatility — reflecting integrated estrogen–gut–metabolic coupling rather than isolated endocrine endpoints [Baker et al., 2017; De Paoli et al., 2021].
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Reproductive hormone balance may influence emotional regulation through convergent effects of oestrogen signalling, progesterone-related pathways, androgen signalling, microbiome-mediated hormone metabolism, and metabolic-endocrine stability.
- Key References:
- Sarkar et al. (2020) — Mechanistic
- Maeng & Beumer (2023) — Preclinical
- de Jong et al. (2024) — Mechanistic
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Medium
- Synthesis: Testosterone signalling and broader reproductive hormone stability may contribute to motivation, persistence, mental stamina, and goal-directed effort, particularly when low androgen tone, stress, ageing, or endocrine transition contexts are relevant.
- Key References:
- Evidence Confidence: Medium
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Hormonal signalling stability may influence perceived cognitive clarity, attentional consistency, and brain fog, especially during periods of endocrine fluctuation or hormone-microbiome disruption.
- Key References:
- Rusch et al. (2023) — Mechanistic
- Proaño et al. (2024) — Preclinical
- de Jong et al. (2024) — Mechanistic
- Evidence Confidence: Low–Medium
4. Mechanistic Basis (Integrated FM Narrative)
BRS-X(Hormones-FM1) integrates neural oestrogen signalling, estrobolome-mediated recycling, progesterone-supportive microbial metabolism, and metabolic-reproductive endocrine coupling into a single cross-system reproductive-hormone regulatory state.
4.1 Core Primary Mechanisms
-
BRS-X(Hormones-PM1) — Oestrogen Signalling Stability Oestrogen-mediated signalling relevant to dopamine tone, cognitive stability, and emotional regulation across menstrual and perimenopausal contexts.
-
BRS-X(Hormones-PM2) — Estrobolome Regulation Microbiome-mediated oestrogen deconjugation, recycling, and elimination through beta-glucuronidase activity and enterohepatic circulation.
-
BRS-X(Hormones-PM3) — Progesterone-Supportive Microbial Metabolism Microbial and SCFA-linked support for progesterone-related hormonal stability.
-
BRS-X(Hormones-PM4) — Metabolic-Reproductive Hormone Integration Coordination between insulin regulation, gut barrier/microbial function, and reproductive hormone balance.
-
BRS-X(Hormones-PM5) — Testosterone Signalling Stability Integrated regulation of testosterone availability and androgen receptor signalling influencing behavioural activation, motivation, and goal-directed effort.
-
BRS-X(Hormones-PM6) — Androgen-Microbiome Regulation Microbiome-mediated regulation of androgen metabolism, recycling, and systemic androgen exposure through microbial steroid-transforming enzymes.
4.2 Integrated Functional Narrative
Together, these PMs operationalise BRS-X(Hormones-FM1) as coordinated reproductive-hormone regulation spanning direct neural oestrogen signalling, gut-mediated sex-hormone recycling, progesterone-supportive microbial context, insulin-linked metabolic integration, androgen neural signalling, and microbial androgen metabolism. Neurocognitive stability emerges from the interaction of these layers rather than any single hormone pathway — consistent with integrative reviews of the estrogen–gut microbiome axis, estrobolome-mediated enterohepatic recycling, estrogen–insulin coupling, and sex-modulated microbiota–gut–brain signalling [Baker et al., 2017; Kwa et al., 2016; De Paoli et al., 2021; Jaggar et al., 2020].
4.3 Suboptimal Function & Its Effects
Low fermentable fibre availability may reduce BRS5(KC1) — Fermentable Fibre Availability, limiting substrate for microbial beta-glucuronidase activity, butyrate-producing taxa, and barrier-supportive ecology. Fibre-poor dietary patterns can reduce microbial diversity and immune-metabolic resilience in ways that weaken gut-ecology support for integrated endocrine regulation [Wastyk et al., 2021]. Gut dysbiosis with lower microbial diversity may also impair estrogen deconjugation and enterohepatic recycling, shifting systemic estrogen exposure [Baker et al., 2017; Kwa et al., 2016]. Ultra-processed low-fibre patterns, low plant diversity, and glycaemic instability may further uncouple metabolic-reproductive integration from gut-mediated hormone recycling [De Paoli et al., 2021].
These pressures may weaken BRS-X(Hormones-PM2) — Estrobolome Regulation, reduce progesterone-supportive microbial context on BRS-X(Hormones-PM3) — Progesterone-Supportive Microbial Metabolism, impair BRS-X(Hormones-PM4) — Metabolic-Reproductive Hormone Integration, destabilise androgen signalling on BRS-X(Hormones-PM5) — Testosterone Signalling Stability, and disrupt microbial androgen metabolism on BRS-X(Hormones-PM6) — Androgen-Microbiome Regulation. At the FM level, this may shift toward greater hormonal volatility and less stable neurocognitive context.
4.4 Evidence Highlights
Introduction/Summary
The studies below support reproductive hormone balance & neurocognitive regulation as an integrated FM state emerging from coordinated child PM biology — mechanism-qualifying findings that refine framework interpretation, not phenome/outcome science (which belongs in §3).
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Oestrogen may influence dopaminergic tone and synaptic signalling context relevant to attention and motivation biology — estrogen shapes dopamine-dependent cognitive processes in a baseline-dopamine-dependent manner [Jacobs and D'Esposito, 2011].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Estradiol may rapidly modulate glutamatergic synapse properties across cycle-linked context in striatal regions — linking reproductive hormone fluctuation to excitatory signalling architecture rather than isolated transmitter production [Proaño et al., 2024].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Gut bacteria with beta-glucuronidase activity can deconjugate oestrogen metabolites in the intestinal lumen, influencing whether oestrogens are recycled via enterohepatic circulation or eliminated — central to microbiome-mediated oestrogen recycling and elimination [Hu et al., 2023]; [Sui et al., 2021]; [Ervin et al., 2019].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Microbial beta-glucuronidase enzymes reactivate conjugated oestrogens as components of the estrobolome, modulating systemic oestrogen exposure independent of ovarian production alone [Ervin et al., 2019]; [Sui et al., 2021].
- Key References:
5. Connected Mechanisms
- BRS1(FM1) — Monoaminergic Function — monoaminergic Function
- BRS5-FM2-PM5 — SCFA Production & Signalling — sCFA Production & Signalling
- BRS5(FM1) — Gut Barrier Integrity & Immune Interface — gut Barrier Integrity & Immune Interface
- BRS6(FM1) — Glycaemic–Insulin Stability & Cognitive Energy Availability — Direct oestrogen neural signalling
6. References
- Baker et al. (2017) — Physiological and Clinical Implications
- Sarkar et al. (2020) — Role of the Microbiome in the Neurobiology of Social Behaviour
- Maeng & Beumer (2023) — Estrogen and Gut Microbiome-brain Axis Interactions in Fear Extinction
- de Jong et al. (2024) — A Female-Specific Treatment Group for ADHD---Description of the Programme and Qualitative Analysis
- Celec et al. (2015) — On the Effects of Testosterone on Brain Behavioral Functions
- Hudson et al. (2023) — Symptomatic Benefits of Testosterone Treatment in Patient Subgroups
- Rusch et al. (2023) — Gut Microbiota and Hypothalamic-pituitary-adrenal Axis
- Proaño et al. (2024) — Sex Steroid Hormones, the Estrous Cycle, and Rapid Modulation of Glutamatergic Synapse
- Kwa et al. (2016) — Intestinal Microbiome and Estrogen Receptor--Positive Female Breast Cancer
- d'Afflitto et al. (2022) — Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity---A Systematic
- De Paoli et al. (2021) — Role of Estrogen in Insulin Resistance
- Jaggar et al. (2020) — Sex and the Microbiota-gut-brain Axis Across the Lifespan
- Wastyk et al. (2021) — Gut-microbiota-targeted Diets Modulate Human Immune Status